Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5063
Gene Symbol: PAK3
PAK3
0.410 Biomarker disease GENOMICS_ENGLAND X-linked mild non-syndromic mental retardation with neuropsychiatric problems and the missense mutation A365E in PAK3. 12884430 2003
Entrez Id: 170302
Gene Symbol: ARX
ARX
0.160 GeneticVariation disease BEFREE X-linked lissencephaly with corpus callosum agenesis and ambiguous genitalia in genotypic males is associated with mutations of the ARX gene. 16724181 2006
Entrez Id: 170302
Gene Symbol: ARX
ARX
0.160 GeneticVariation disease BEFREE X-linked lissencephaly with corpus callosum agenesis and ambiguous genitalia in genotypic males is associated with mutations of the ARX gene. 15921228 2005
Entrez Id: 3897
Gene Symbol: L1CAM
L1CAM
0.200 GeneticVariation disease BEFREE X-linked hydrocephalus, MASA syndrome and certain forms of X-linked spastic paraplegia and agenesis of corpus callosum are now known to be due to mutations in the gene for the neural cell adhesion molecule L1 (19, 30). 9266556 1997
Entrez Id: 31
Gene Symbol: ACACA
ACACA
0.100 PosttranslationalModification disease BEFREE WT showed an increase in the phosphorylation of ACC (Ser79) 2-hours after exercise and return to normal after 24-hours of exercise (p-value < 0.05), kinects that was not observed in AdKO mice. 30903866 2019
Entrez Id: 9790
Gene Symbol: BMS1
BMS1
0.100 PosttranslationalModification disease BEFREE WT showed an increase in the phosphorylation of ACC (Ser79) 2-hours after exercise and return to normal after 24-hours of exercise (p-value < 0.05), kinects that was not observed in AdKO mice. 30903866 2019
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 Biomarker disease BEFREE Within this dataset, the expression profiles of five genes were validated by real time-PCR (RT-PCR) in a cohort of 34 adrenocortical tissues (six AA and one ACC with CTNNB1 mutations, 13 AA and four ACC with WT CTNNB1, and 10 normal adrenal glands) and two human ACC cell lines. 21565795 2011
Entrez Id: 6696
Gene Symbol: SPP1
SPP1
0.010 AlteredExpression disease BEFREE With tissue arrays, we confirmed high OPN expression in 147 ACC samples. 19326399 2009
Entrez Id: 4602
Gene Symbol: MYB
MYB
0.100 Biomarker disease BEFREE With bisulfite genomic sequencing, we found no detectable methylation in the CpG islands of MYB in either ACC or normal salivary gland tissues. 21324728 2011
Entrez Id: 10723
Gene Symbol: SLC12A7
SLC12A7
0.030 Biomarker disease BEFREE Whole-exome sequencing and TaqMan Copy Number Assays demonstrated SLC12A7 amplifications in 68.4% and 65.4% of ACCs tested, respectively. 26454676 2016
Entrez Id: 2308
Gene Symbol: FOXO1
FOXO1
0.020 Biomarker disease BEFREE While FOXO3 expression remained unchanged in ACCs, FOXO1 expression was found to be significantly downregulated in 19/20 ACAs and 9/10 ACCs (p<0.0001 and p<0.05, respectively), suggesting a global role for FOXO1 suppression in promoting and maintaining adrenocortical dedifferentiation. 28641336 2017
Entrez Id: 2309
Gene Symbol: FOXO3
FOXO3
0.010 AlteredExpression disease BEFREE While FOXO3 expression remained unchanged in ACCs, FOXO1 expression was found to be significantly downregulated in 19/20 ACAs and 9/10 ACCs (p<0.0001 and p<0.05, respectively), suggesting a global role for FOXO1 suppression in promoting and maintaining adrenocortical dedifferentiation. 28641336 2017
Entrez Id: 4233
Gene Symbol: MET
MET
0.020 Biomarker disease BEFREE While c-MET expression is not a prognostic factor in ACC, its role as a predictive marker of benefit from MET inhibitors deserves further investigation. 25923130 2015
Entrez Id: 2353
Gene Symbol: FOS
FOS
0.010 Biomarker disease BEFREE Western blot analysis of MAPK, AKT, activator protein-1, and nuclear factor-κB signaling revealed that the ACC cell lines are unresponsive to lipopolysaccharide action. 20826579 2010
Entrez Id: 3726
Gene Symbol: JUNB
JUNB
0.010 Biomarker disease BEFREE Western blot analysis of MAPK, AKT, activator protein-1, and nuclear factor-κB signaling revealed that the ACC cell lines are unresponsive to lipopolysaccharide action. 20826579 2010
Entrez Id: 2354
Gene Symbol: FOSB
FOSB
0.010 Biomarker disease BEFREE Western blot analysis of MAPK, AKT, activator protein-1, and nuclear factor-κB signaling revealed that the ACC cell lines are unresponsive to lipopolysaccharide action. 20826579 2010
Entrez Id: 3727
Gene Symbol: JUND
JUND
0.010 Biomarker disease BEFREE Western blot analysis of MAPK, AKT, activator protein-1, and nuclear factor-κB signaling revealed that the ACC cell lines are unresponsive to lipopolysaccharide action. 20826579 2010
Entrez Id: 3725
Gene Symbol: JUN
JUN
0.010 Biomarker disease BEFREE Western blot analysis of MAPK, AKT, activator protein-1, and nuclear factor-κB signaling revealed that the ACC cell lines are unresponsive to lipopolysaccharide action. 20826579 2010
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 AlteredExpression disease BEFREE We verified that Nutlin-3a inhibited cellular proliferation in ACC cell line NCI-H295R which harbored CTNNB1 mutation but not in SW13 cells which did not. 29532999 2018
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.040 AlteredExpression disease BEFREE We used high- (ACCM) and low- (ACC2) metastasis cell lines of human adenoid cystic carcinoma (ACC) as an experimental model to study metastatic mechanisms and compare their expression levels for angiogenic-related factor vascular endothelial growth factor (VEGF). 24510998 2014
Entrez Id: 597
Gene Symbol: BCL2A1
BCL2A1
0.040 Biomarker disease BEFREE We used high- (ACCM) and low- (ACC2) metastasis cell lines of human adenoid cystic carcinoma (ACC) as an experimental model to study metastatic mechanisms and compare their expression levels for angiogenic-related factor vascular endothelial growth factor (VEGF). 24510998 2014
Entrez Id: 32
Gene Symbol: ACACB
ACACB
0.040 Biomarker disease BEFREE We used high- (ACCM) and low- (ACC2) metastasis cell lines of human adenoid cystic carcinoma (ACC) as an experimental model to study metastatic mechanisms and compare their expression levels for angiogenic-related factor vascular endothelial growth factor (VEGF). 24510998 2014
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 Biomarker disease BEFREE We thus aimed at analyzing whether activation of mTOR with a concomitant loss of p53 may initiate ACC. 26683340 2015
Entrez Id: 2475
Gene Symbol: MTOR
MTOR
0.030 AlteredExpression disease BEFREE We thus aimed at analyzing whether activation of mTOR with a concomitant loss of p53 may initiate ACC. 26683340 2015
Entrez Id: 2736
Gene Symbol: GLI2
GLI2
0.110 Biomarker disease BEFREE We suggest that GLI2 is a dosage-sensitive gene that may be responsible for the agenesis of corpus callosum observed in the proband. 27346851 2016